SCHEMBL7870899

SCHEMBL7870899

COc1ccc(C(=O)N2CC(CN3CCC(c4ccc(F)cc4)CC3)C(c3ccsc3)C2)cc1

nearest known ligand 0.56

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 14/20 0.56
PARP10 Q53GL7 1/20 0.45
HSD11B1 P28845 2/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7868441 0.91 CCR5 (0.68) CCR5HSD11B1ALDH1A1LMNA
SCHEMBL7869857 0.91 CCR5 (0.56) CCR5
SCHEMBL7870886 0.89 CCR5 (0.67) CCR5
SCHEMBL7869940 0.89 CCR5 (0.70) CCR5
SCHEMBL7874866 0.89 CCR5 (0.58) CCR5
SCHEMBL7871271 0.86 CCR5 (0.52) CCR5
SCHEMBL7871892 0.86 CCR5 (0.54) CCR5HSD11B1
SCHEMBL7868439 0.86 CCR5 (0.50) CCR5
SCHEMBL7868438 0.86 CCR5 (0.50) CCR5
SCHEMBL7869790 0.86 CCR5 (0.53) CCR5HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6303593-B1 FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS MERCK & CO., INC. 2001-10-16 US claimed
US-6303593-B1 FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS MERCK & CO., INC. 2001-10-16 US disclosed